Latest filing published 30 May 2019 for BICYCLE THERAPEUTICS plc.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +47.0%Entry US$11.69 · Close at T+365 US$17.18
- -92.3%Entry US$2,773.80 · Close at T+365 US$214.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
SVLSF V, LLC: trading record in brief
SVLSF V, LLC has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Sutro Biopharma, Inc., X4 Pharmaceuticals, Inc and Astria Therapeutics, Inc. Between 30 June 2015 and 28 May 2019, the trades on record add up to 41 filings.
On the market, this insider has only ever bought: 6 purchases, €13.3M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2019 to date brings 2 purchases and no sales.
Half of the purchases are above €2.1M and half below. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -21.8%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 30 May 2019, the filings show a transaction in BICYCLE THERAPEUTICS plc. The last insider purchase was made public on 30 May 2019, 2,720 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to SVLSF V, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 874,709 sharesOrdinary SharesSEC:0001104659-19-032917:0
- 623,196 sharesOrdinary SharesSEC:0001104659-19-032917:1
- 18,485 sharesOrdinary SharesSEC:0001104659-19-032917:2
- 13,169 sharesOrdinary SharesSEC:0001104659-19-032917:3
- 377,732 shares@ US$14.0097.9% of flowOrdinary SharesSEC:0001104659-19-032917:4Canonical exit: 26 Aug 2019 (T+90)
- 7,983 shares@ US$14.002.1% of flowOrdinary SharesSEC:0001104659-19-032917:5Canonical exit: 26 Aug 2019 (T+90)
- 943 sharesCommon StockSEC:0001209191-18-052851:0
- 7,610 sharesCommon StockSEC:0001209191-18-052851:1
- 2,399 sharesCommon StockSEC:0001209191-18-052851:2
- 79,467 sharesCommon StockSEC:0001209191-18-052851:3
- 641,440 sharesCommon StockSEC:0001209191-18-052851:4
- 202,115 sharesCommon StockSEC:0001209191-18-052851:5
- 758 sharesCommon StockSEC:0001209191-18-052851:6
- 6,128 sharesCommon StockSEC:0001209191-18-052851:7
- 1,931 sharesCommon StockSEC:0001209191-18-052851:8
- 341,030 sharesCommon StockSEC:0001209191-18-052851:9
- 270,690 sharesCommon StockSEC:0001209191-18-052851:10
- 251,783 sharesCommon StockSEC:0001209191-18-052851:11
- 7,207 sharesCommon StockSEC:0001209191-18-052851:12
- 5,721 sharesCommon StockSEC:0001209191-18-052851:13
- 5,320 sharesCommon StockSEC:0001209191-18-052851:14
- 19,128 sharesCommon StockSEC:0000899243-17-027009:0
- 404 sharesCommon StockSEC:0000899243-17-027009:1
- 247,010 sharesCommon StockSEC:0000899243-17-027009:2
- 5,219 sharesCommon StockSEC:0000899243-17-027009:3
25 of 41 declarations